Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 501–600 of 1,004
Mito-Nuclear Communication by Mitochondrial Metabolites and Its Regulation by B-Vitamins
Janssen, J. J. E., Grefte, S., Keijer, J., & de Boer, V. C. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00078 · Cited by 72
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ji, Z., Shen, J., Lan, Y., Yi, Q., & Liu, H. (2023) · MedComm · doi:10.1002/mco2.308 · Cited by 81
Suarez‐Carmona, M., Bourcy, M., Lesage, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J., Delvenne, P., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4546 · Cited by 71
“Although a major and well-described effect of EMT-TFs is E-cadherin repression [6–8], EMT-TFs can activate or repress a variety of target genes [9–11] (for review, see [12]).”
BackgroundSnail1-dependent control of embryonic stem cell pluripotency and lineage commitment
Lin, Y., Li, X.-Y., Willis, A. L., Liu, C., Chen, G., & Weiss, S. J. (2014) · Nature Communications · doi:10.1038/ncomms4070 · Cited by 77
Du, J. C., Hong, S., Dong, L., Cheng, B., Lin, L., Zhao, B. T., Chen, Y., & Chen, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.636969 · Cited by 71
“Because hypersialylation was reported to be accompanied by high metastasis of cancer cells (11–13), which are considered to be in the mesenchymal state (30), we asked whether the suppression of sialylation during EMT would be reverted after the completion of EMT.”
Xiao, S., Liu, L., Lu, X., Long, J., Zhou, X., & Fang, M. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1937-y · Cited by 70
Tan, E.-J., Kahata, K., Idås, O., Thuault, S., Heldin, C.-H., & Moustakas, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1293 · Cited by 68
“In addition to genome-wide expression reprogramming caused by the classical EMTTFs (4,5), dynamic chromatin modifications also occur during EMT in regulating both epithelial and mesenchymal genes (9,24,37,38).”
InfluentialMicroRNA control of epithelial‐mesenchymal transition in cancer stem cells
Hao, J., Zhang, Y., Deng, M., Ye, R., Zhao, S., Wang, Y., Li, J., & Zhao, Z. (2014) · International Journal of Cancer · doi:10.1002/ijc.28761 · Cited by 71
“Numerous miRNAs have been implicated in the complex regulatory loops that control epithelial plasticity, and are integrated into EMT regulatory networks.(32,33) The role of miRNAs in regulating EMT process was first demonstrated in 2008 with four studies from independent groups indicated a role of miR-200 family in re…”
BackgroundEpithelial-to-Mesenchymal Transition in Renal Neoplasms
He, H., & Magi‐Galluzzi, C. (2014) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000018 · Cited by 68
Hiraoka, T., Hirota, Y., Saito‐Fujita, T., Matsuo, M., Egashira, M., Matsumoto, L., Haraguchi, H., Dey, S. K., Furukawa, K. S., Fujii, T., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87591 · Cited by 71
“EMT is a phenomenon observed in the processes of cancer progression and tissue repair (60, 61), and the paracrine mechanism, typified by Wnt signaling and Hedgehog signaling, is a key for tissue polarity determination during organogenesis (62–65).”
Taube, J. H., Sphyris, N., Johnson, K. S., Reisenauer, K. N., Nesbit, T. A., Joseph, R., Vijay, G. V., Sarkar, T. R., Bhangre, N., Song, J. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19214 · Cited by 75
Heilmann, K., Tóth, R., Bossmann, C., Klimo, K., Plass, C., & Gerhäuser, C. (2017) · Oncogene · doi:10.1038/onc.2017.246 · Cited by 72
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
Preca, B., Bajdak-Rusinek, K., Mock, K., Lehmann, W., Sundararajan, V., Bronsert, P., Matzke‐Ogi, A., Orian‐Rousseau, V., Brabletz, S., Brabletz, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14563 · Cited by 73
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
“Twist1 is negatively regulated by miR-186, which inhibits EMT [3, 17, 20, 21, 24, 29, 96].”
BackgroundEpigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
Monteiro‐Reis, S., Lobo, J., Henrique, R., & Jerónimo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020297 · Cited by 89
“Various factors and cellular environmental conditions are known to induce EMT, by triggering a cascade of signalling pathways that lead to post-transcriptional modification of the most well-known EMT transcription factors (EMT-TFs): Snail, Slug, ZEB1, ZEB2, and TWIST [21,22].”
BackgroundInfluentialThe emergence of melatonin in oncology: Focus on colorectal cancer
Gil‐Martín, E., Egea, J., Reiter, R. J., & Romero, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21582 · Cited by 71
“the initial EMT, the transcriptional reprogramming of polarized epithelial cells to endow primary carcinoma cells with a more undifferentiated nonpolarized and motile‐mesenchymal morphology.(215) These phenotypic changes are”
BackgroundLncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR‐515‐5p/GINS2 axis
Dai, G., Huang, C., Yang, J., Jin Wei, L. U., Fu, K., Yuan, F., Zhu, J., & Xue, B. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15564 · Cited by 70
Focal adhesion kinase (FAK) perspectives in mechanobiology: implications for cell behaviour
Tomakidi, P., Schulz, S., Proksch, S., Weber, W., & Steinberg, T. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1945-2 · Cited by 73
Zhang, L., Sha, J., Yang, G., Huang, X., Bo, J., & Huang, Y. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1312237 · Cited by 69
“Epithelial markers including E-cadherin and g-catenin are downregulated, while mesenchymal markers such as Vimentin, Snail, Slug, ZEB1, and ZEB2 are increased.(35) Multiple studies have revealed that EMT-type cells acquire enhanced migration and Figure 3.”
BackgroundLong non-coding RNAs in Colorectal Cancer: Progression and Future Directions
Yang, Y. P., Peng, J., Sanjun, C., & Ma, Y. (2017) · Journal of Cancer · doi:10.7150/jca.19794 · Cited by 72
“Recent preclinical or clinical research has implicated the activation of the EMT program and its reverse program in the metastatic process in CRC[106].”
BackgroundHAS2 and CD44 in Breast Tumorigenesis
Heldin, P., Basu, K., Kozlova, I., & Porsch, H. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00008-3 · Cited by 72
Cho, S., Park, C., Na, D., Han, J. Y., Lee, J. L., Park, O.-K., Zhang, C., Sung, C. O., Moon, H. E., Kim, Y., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.9 · Cited by 66
Gasca, J., Flores, M. L., Jiménez‐Guerrero, R., Sáez, M. E., Barragán, I., Ruíz‐Borrego, M., Tortolero, M., Romero, F., Sáez, C., & Japón, M. Á. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00322-x · Cited by 79
Chaves, L. P., Melo, C. M., Saggioro, F. P., dos Reis, R. B., & Squire, J. A. (2021) · Genes · doi:10.3390/genes12121900 · Cited by 78
Emerging mechanisms progress of colorectal cancer liver metastasis
Zhao, W., Dai, S., Yue, L., Fan, X., Gu, J. H., Dai, X., & Qian, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1081585 · Cited by 73
“High expression of ZEB2 in E-cadherin-positive MDCK cells resulted in significant down-regulation of E-cadherin, loss of cell adhesion, and induction of invasion (56).”
BackgroundInfluentialZeb1 and S nail1 engage mi R ‐200f transcriptional and epigenetic regulation during EMT
Díaz‐López, A., Díaz‐Martín, J., Moreno‐Bueno, G., Cuevas, E. P., Santos, V., Olmeda, D., Portillo, F., Palacios, J., & Cano, A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29177 · Cited by 73
“Both EMT and MET processes imply a tightly regulated program of epithelial plasticity, including transcriptional and translational machineries, expression of noncoding RNAs, alternative splicing and protein stability mechanisms.(7) A plethora of signaling pathways are in charge of EMT activation, including: TGFb, TNFa…”
BackgroundCufí, S., Bonavia, R., Vázquez‐Martín, A., Corominas-Faja, B., Oliveras‐Ferraros, C., Cuyàs, E., Martín-Castillo, B., Barrajón‐Catalán, E., Visa, J., Segura‐Carretero, A., et al. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.063 · Cited by 71
MicroRNAs associated with small bowel neuroendocrine tumours and their metastases
Miller, H. C., Frampton, A. E., Malczewska, A., Ottaviani, S., Stronach, E. A., Flora, R., Kaemmerer, D., Schwach, G., Pfragner, R., Faiz, O. D., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0044 · Cited by 70
Wang, X., Dai, X., Zhang, X., Ma, C., Li, X., Xu, T., & Lan, Q. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36549 · Cited by 70
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
Terraneo, N., Jacob, F., Dubrovska, A., & Grünberg, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00319 · Cited by 68
“These TFs coordinate changes in gene expression resulting in suppression of genes associated with the epithelial state, like E-cadherin, and in upregulation of genes correlated with the mesenchymal state, including N-cadherin and vimentin (162).”
BackgroundJolly, M. K., Tripathi, S. C., Somarelli, J. A., Hanash, S., & Levine, H. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12084 · Cited by 70
“Thus, EMT and MET typically involve widespread changes in gene expression, microRNAs, and epigenetic profiles, as well as cytoskeletal reprogramming (De Craene and Berx, 2013).”
Song, J., Wang, W., Wang, Y., Qin, Y., Wang, Y., Zhou, J., Wang, X., Zhang, Y., & Wang, Q. (2019) · BMC Cancer · doi:10.1186/s12885-019-5885-9 · Cited by 70
Palamaris, K., Felekouras, E. S., & Sakellariou, S. (2021) · Cancers · doi:10.3390/cancers13215532 · Cited by 76
“In the context of malignancy, the acquisition of mesenchymal features driven by EMT enables cancer cells to complete many steps of the invasion-metastasis sequence, such as invasion of surrounding tissues, vascular intravasation, and colonization of distant organs [30,31].”
BackgroundRegulation of EMT by KLF4 in Gastrointestinal Cancer
Cui, J., Shi, M., Quan, M., & Xie, K. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113136660104 · Cited by 65
“Ever-increasing evidences have revealed that a number of transcription factors play critical role in the initiation and execution of EMT, including Snail1 (Snail), Snail2 (Slug), ZEB1, ZEB2 (Sip1), Twist1, FoxC2, E47, KLF8, goosecoid, Sox9, NF-κB et al [80].”
BackgroundVitamin D and the Epithelial to Mesenchymal Transition
Larriba, M. J., de Herreros, A. G., & Múñoz, A. (2016) · Stem Cells International · doi:10.1155/2016/6213872 · Cited by 68
“Typical EMT gene reprogramming is mainly orchestrated by key transcription factors including the zinc finger proteins SNAIL1 and SNAIL2, the double zinc finger and homeodomain factors ZEB1 and ZEB2, and the members of the basic-helix-loop-helix family TWIST1 and E47, all known as EMT transcription…”
Pan, Y., Robertson, G., Pedersen, L., Lim, E. L., Hernández-Herrera, A., Rowat, A. C., Patil, S. L., Chan, C., Wen, Y., Zhang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8412 · Cited by 72
“Our sequencing data also identified epithelialmesenchymal transition (EMT) regulators [25] as predicted targets of members of the miR cluster and of the miR-200 family: SNAI1 (miR-510-5p), SNAI2 (miR507, miR-200b-3p), TWIST1 (miR-507, 508-3p, 509-3p), TWIST2 (miR-141-3p, 29b-3p, 29c-3p), ZEB1 (miR-1413p, 200b-3p) and…”
AFAP1‐AS1: A novel oncogenic long non‐coding RNA in human cancers
Zhang, F., Li, J., Xiao, H., Zou, Y., Liu, Y., & Huang, W. (2017) · Cell Proliferation · doi:10.1111/cpr.12397 · Cited by 75
Singh, K., Sinha, M., Pal, D., Tabasum, S., Gnyawali, S. C., Khona, D. K., Sarkar, S., Mohanty, S. K., Gonzalez, F. S., Khanna, S., et al. (2019) · Diabetes · doi:10.2337/db19-0202 · Cited by 68
“, miR-200b, miR-200c, miR-9) and other microenvironmental cues (15,47) govern EMT.”
BackgroundUpregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT
Zhang, G., & Zhang, G. (2019) · Oncology Letters · doi:10.3892/ol.2019.10049 · Cited by 67
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Zong, X., & Nephew, K. P. (2019) · Cancers · doi:10.3390/cancers11070934 · Cited by 68
Papanikolaou, S., Vourda, A., Syggelos, S. A., & Gyftopoulos, K. (2021) · Cancers · doi:10.3390/cancers13112795 · Cited by 76
“Their expression is an early event in EMT, suggesting key roles in development, fibrosis, and cancer [15].”
BackgroundEmerging roles of CircRNA-miRNA networks in cancer development and therapeutic response
Hashemi, M., Khosroshahi, E. M., Daneii, P., Hassanpoor, A., Eslami, M., Koohpar, Z. K., Asadi, S., Zabihi, A., Jamali, B., Ghorbani, A., et al. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.09.006 · Cited by 70
“EMT involves the transformation of cells from an epithelial phenotype to a mesenchymal phenotype, a change that underlies key cancer attributes such as metastasis, stemness, and resistance to therapy [211 – 213].”
BackgroundWei, Z., Shan, Z., & Shaikh, Z. A. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.022 · Cited by 64
“Change in the expression of these markers is a hallmark of EMT (De Craene and Berx, 2013).”
Liu, R., Li, X., Hylemon, P. B., & Zhou, H. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.05.015 · Cited by 66
Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
Marques, P., Barry, S., Carlsen, E., Collier, D., Ronaldson, A., Awad, S., Dorward, N., Grieve, J., Mendoza, N., Muquit, S., et al. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0327 · Cited by 71
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
Pattabiraman, D. R., & Weinberg, R. A. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030957 · Cited by 62
Zeb2 drives invasive and microbiota-dependent colon carcinoma
Slowicka, K., Πέττα, Ι., Blancke, G., Hoste, E., Dumas, E., Sze, M., Vikkula, H., Radaelli, E., Haigh, J. J., Jonckheere, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0070-2 · Cited by 66
Self-citationZeng, Q., Che, Y., Zhang, Y., Chen, M., Guo, Q., & Zhang, W. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s254218 · Cited by 73
Zhang, W., Luo, C. H., Huang, C., Pu, F.-Q., Zhu, J.-F., & Zhu, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174041 · Cited by 67
Sulaiman, S. A., Mutalib, N. A., & Jamal, R. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00271 · Cited by 64
“The epithelial tumor cells favor EMT to gain migration and invasive characteristics, however, when they reach a new secondary site, MET is activated to form macro metastasis (Craene and Berx, 2013; Nieto, 2013).”
BackgroundPrasad, C. P., Chaurasiya, S. K., Guilmain, W., & Andersson, T. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0421-0 · Cited by 70
“Cancer cells undergoing EMT show a loss of cell-cell contact and polarity and acquire migratory and invasive properties [18, 19].”
Wu, C., Zhuang, Y., Jiang, S., Tian, F., Teng, Y., Chen, X., Zheng, P.-Q., Liu, S., Zhou, J., Wu, J., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.005 · Cited by 63
Zhu, G., Song, P., Zhou, H., Shen, X., Wang, J., Ma, X., Gu, Y., Liu, D., Feng, A., Qian, X., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7751 · Cited by 65
“EMT has also been demonstrated to be induced by the expression of other EMT-associated proteins, including N-cadherin and zinc finger E‑box binding homeobox 2 (ZEB2; also known as SIP1) in various different cancer types, including head and neck squamous cell carcinoma (HNSCC) (12).”
InfluentialWang, X., Li, H., Lu, X., Wen, C., Huo, Z., Shi, M., Tang, X., Chen, H., Peng, C., Fang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0965-3 · Cited by 65
Feng, S., Cai, X., Li, Y., Jian, X., Zhang, L., & Li, B. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1070-x · Cited by 63
RetractedContribution of Epithelial Plasticity to Therapy Resistance
Santamaría, P. G., Moreno‐Bueno, G., & Cano, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050676 · Cited by 68
“Immunotherapy, currently focused on immuno-inhibitors targeting the interaction of programmed cell death 1 (PD-1) with PD ligand 1 (PD-L1) or cytotoxic T-lymphocyte antigen 4 (CTLA-4) (reviewed in References [145,146]) provides clear benefit for some cancer patients.”
BackgroundInfluentialMetastasis: crosstalk between tissue mechanics and tumour cell plasticity
Coban, B., Bergonzini, C., Zweemer, A. J. M., & Danen, E. H. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01150-7 · Cited by 71
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?
Ansieau, S., Collin, G., & Hill, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00353 · Cited by 62
“With inclusion of miRNAs, these factors constitute a complex interactome, able to sensor multiple signals received from the proximal microenvironment and relay them onto gene expression (2, 3).”
BackgroundPentimento: Neural Crest and the origin of mesectoderm
Weston, J. A., & Thiery, J. P. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2014.12.035 · Cited by 68
“In turn, the expression of the Snail family genes is responsive to a regulatory pathway that includes Zeb-2, NF-κB, and Twist-1 (De Craene and Berx, 2013; Lim and Thiery, 2012; Nieto, 2002; Peinado et al., 2007; Thiery et al., 2009; Zhang and Klymkowsky, 2009), and some of these genes are…”
BackgroundAn integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
Collord, G., Tarpey, P. S., Kurbatova, N., Martincorena, I., Morán, S., de Moura, M. C., Nagy, T., Bignell, G. R., Maura, F., Young, M. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31659-0 · Cited by 66
Dasgupta, P., Kulkarni, P., Majid, S., Hashimoto, Y., Shiina, M., Shahryari, V., Bhat, N. S., Tabatabai, L., Yamamura, S., Saini, S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02877-0 · Cited by 61
Chen, J., Zhao, D., Zhang, L., Zhang, J., Xiao, Y., Wu, Q., Wang, Y., & Zhan, Q. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00903-z · Cited by 71
“CCL22 induces EMT and matrix metalloproteinase (MMP) secretion in ESCC cells EMT is the initial step of tumor invasion and metastasis in cancers, including in ESCC [35, 36].”
BackgroundPrislei, S., Martinelli, E., Zannoni, G. F., Petrillo, M., Filippetti, F., Mariani, M., Mozzetti, S., Raspaglio, G., Scambia, G., & Ferlini, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3943 · Cited by 66
“Since ZEB2 gene is modulated at posttranscriptional level by miRNAs activity [7] and it is well known the functional interplay between miRNAs and RNA-binding proteins [19], we set out to investigate if ZEB2 can be modulated by RNA-binding proteins.”
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization
Magrini, E. I., Villa, A., Angiolini, F., Doni, A., Mazzarol, G., Rudini, N., Maddaluno, L., Komuta, M., Topal, B., Prenen, H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70683 · Cited by 64
Koelzer, V. H., Lugli, A., Dawson, H., Hädrich, M., Berger, M. D., Borner, M., Mallaev, M., Galván, J. A., Amsler, J., Schnüriger, B., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-81 · Cited by 71
“Indeed, cancer cells involved in epithelial-mesenchymal transition (EMT) are also known in the literature as “tumor buds” or “EMTlike tumor cells” and represent a morphological parameter of tumor progression and worse survival [4-8].”
BackgroundNotch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells
Zhou, J., Jain, S., Azad, A. K., Xu, X., Yu, H. C., Xu, Z., Godbout, R., & Fu, Y. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.016 · Cited by 64
“Epithelial-mesenchymal transition (EMT), which is a critical event in tumour progression, can be induced by the tumor microenvironment signals and/or activation of oncogenes that lead to upregulation of EMT transcription factors (EMT-TFs), including the ZEB, Snail and Twist families [1-3].”
BackgroundInfluentialBottai, G., Raschioni, C., Székely, B., Tommaso, L. D., Szász, A. M., Losurdo, A., Győrffy, B., Ács, B., Torrisi, R., Karachaliou, N., et al. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.33 · Cited by 64
Santolla, M. F., Vivacqua, A., Lappano, R., Rigiracciolo, D. C., Cirillo, F., Galli, G. R., Talia, M., Brunetti, G., Miglietta, A., Belfiore, A., et al. (2019) · Cells · doi:10.3390/cells8030223 · Cited by 64
“In this context, it has been reported that EMT may prompt diverse processes of the metastatic cascade [71,72].”
BackgroundSzymura, S. J., Zaemes, J. P., Allison, D. F., Clift, S. H., D'Innocenzi, J., Gray, L. G., McKenna, B. D., Morris, B. B., Bekiranov, S., LeGallo, R. D., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0335-5 · Cited by 68
Hou, Y., Zhen, J., Xu, X., Zhen, K., Zhu, B., PAN, R., & Zhao, C. (2015) · Oncology Letters · doi:10.3892/ol.2015.3587 · Cited by 60
“Epithelial-to-mesenchymal transition (EMT) has been recognized to be significant physiological process associated with cancer progression and metastasis (17).”
RetractedHe, Z., Yu, L., Luo, S., Li, M., Li, J., Li, Q., Sun, Y., & Wang, C. (2017) · BMC Cancer · doi:10.1186/s12885-017-3121-z · Cited by 63
“EMT has been confirmed to be a critical mechanism for cancer metastasis [21, 22].”
CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma
Wang, G., Tang, J., Zhan, W., Zhang, R., Zhang, M., Liao, D., Wang, X., Wu, Y., & Kang, T. (2017) · Theranostics · doi:10.7150/thno.20717 · Cited by 64
“Overall, CBX8 may function as a tumor suppressor in ESCC, as CBX8 inhibits EMT and metastasis of ESCC.”
BackgroundInfluentialJi, L., Li, X., Zhou, Z., Zheng, Z., Jin, L., & Jiang, F. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.027 · Cited by 67
Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights
Chemi, F., Mohan, S., Guevara, T., Clipson, A., Rothwell, D. G., & Dive, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.672195 · Cited by 64
“EMT program can be stimulated by multiple factors including an activated tumor associated stroma or under hypoxic conditions (62).”
BackgroundSnai1 regulates cell lineage allocation and stem cell maintenance in the mouse intestinal epithelium
Horvay, K., Jardé, T., Casagranda, F., Perreau, V. M., Haigh, K., Nefzger, C. M., Akhtar, R., Gridley, T., Berx, G., Haigh, J. J., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490881 · Cited by 62
“The Snail family of transcription factors have been characterised as master regulators of EMT with fundamental roles during normal embryogenesis (Barrallo-Gimeno & Nieto, 2005; Murray et al , 2007) in addition to promoting tumour invasion (Scheel & Weinberg, 2012; De Craene & Berx, 2013).”
Self-citationFan, Y. J., Wang, Y.-F., Su, H., Fang, N., Zou, C., Li, W., & Fei, Z. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0544-6 · Cited by 60
RetractedPan, C., Yao, G., Liu, B., Ma, T., Xia, Y., Wei, K., Wang, J., Xu, J., Chen, L., & Chen, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480414 · Cited by 59
PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair
Choi, E.-B., Yang, A.-Y., Kim, S. C., Lee, J., Choi, J. K., Choi, C., & Kim, M. Y. (2016) · Oncogene · doi:10.1038/onc.2016.3 · Cited by 62
Shi, J., Qu, Y., Li, X., Sui, F., Yao, D., Yang, Q., Shi, B., Ji, M., & Hou, P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.346 · Cited by 61
“We further tested the effect of EHF on the process of epithelial–mesenchymal transition (EMT), which is one of the critical steps during tumor metastasis including gastric cancer.(30) As shown in Figure 6a, knocking down EHF expression in AGS, BGC823 and SGC7901 cells increased E-cadherin expression, and decreased Vim…”
BackgroundHiramoto, H., Muramatsu, T., Ichikawa, D., Tanimoto, K., Yasukawa, S., Otsuji, E., & Inazawa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04191-w · Cited by 60
Liu, G., Wang, B., Li, S., Jin, Q., & Dai, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27630 · Cited by 59
“EMT has emerged as a key process in development, wound healing, stem cell behaviors, and cancer progressions (De Craene & Berx, 2013; Lamouille, Xu, & Derynck, 2014).”
BackgroundLuo, Y., Ren, Z., Du, B., Xing, S., Huang, S., Li, Y., Lei, Z., Li, D., Chen, H., Huang, Y., et al. (2019) · Molecules · doi:10.3390/molecules24010144 · Cited by 59
“EMT is characterized by morphological changes of cells, the downregulation of epithelial markers (E-cadherin, ZO-1 and Claudin-1), and the upregulation of mesenchymal markers (N-cadherin and vimentin) and transcription factors (snail and slug) [9].”
BackgroundPMEPA1 induces EMT via a non‐canonical TGF‐β signalling in colorectal cancer
Zhang, L., Wang, X., Lai, C., Zhang, H., & Lai, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14261 · Cited by 63
Wang, W., Shang, Y., Li, Y., & Chen, S. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0240-x · Cited by 60
Huang, C., & Chen, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11649 · Cited by 59
“EMT plays a vital role in tumor cell invasion and metastasis (13,14).”
BackgroundLoss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium
Gross, K. M., Zhou, W., Breindel, J. L., Ouyang, J., Jin, D. X., Sokol, E. S., Gupta, P. B., Huber, K., Zou, L., & Kuperwasser, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.043 · Cited by 58
Liu, H., Wang, H., Liu, X., & Yu, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.096 · Cited by 61
Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01127-6 · Cited by 60
Vimentin regulates the assembly and function of matrix adhesions
Ostrowska‐Podhorodecka, Z., & McCulloch, C. A. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12920 · Cited by 63
“genes associated with the mesenchymal cell phenotype, including those encoding N-cadherin, fibronectin, type I collagen, β1 and β3 integrins and, central to the focus of this review, vimentin.(5,7) When vimentin expression in mesenchymal cells is reduced, motility is diminished, and cells adopt the shapes that typify…”
BackgroundLi, H., Zhang, P., Sun, X., Sun, Y., Shi, C., Liu, H., & Liu, X. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3144 · Cited by 58
“MicroRNAs (miRNAs) have been see as key post-transcriptional level regulators of gene expression (12).”
RetractedZhao, P., Guan, H., Dai, Z.-J., Ma, Y., Liu, X., & Wang, X.-J. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14685034103554 · Cited by 59
The Histone Variant H2A.Z Is a Master Regulator of the Epithelial-Mesenchymal Transition
Domaschenz, R., Kurscheid, S., Nekrasov, M., Han, S., & Tremethick, D. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.086 · Cited by 63
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control
Antognelli, C., Cecchetti, R., Riuzzi, F., Peirce, M. J., & Talesa, V. N. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13581 · Cited by 60
“28 The mechanisms that control the process of EMT in cancer cells are complex and still emerging.”
BackgroundZhao, B., Liu, L., Mao, J., Zhang, Z., Wang, Q., & Li, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0348-9 · Cited by 62
Wu, Y.-M., Chen, Z.-J., Liu, H., Wei, W.-D., Lu, L.-L., Yang, X., Liang, W.-T., Liu, T., Liu, H.-L., Du, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4436 · Cited by 65
“Activation of multiple cellular signal pathways such as MAPK, PI3K, NF-κB, and Wnt/βcatenin also can trigger the EMT process [5, 7].”
BackgroundInfluentialThe EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
Mock, K., Preca, B., Brummer, T., Brabletz, S., Stemmler, M. P., & Brabletz, T. (2015) · Oncotarget · doi:10.18632/oncotarget.3882 · Cited by 63
“The EMT program is induced by stromal derived factors like transforming growth factor β (TGFβ) and converges in the activation of so-called EMT-inducers, particularly of the Snail- and ZEB-family (zinc finger E-box binding homeobox; ZEB1 and ZEB2) in the tumor cells [4].”
BackgroundJin, M. L., Kim, Y. W., Jin, H. L., Kang, H., Lee, E. K., Stallcup, M. R., & Jeong, K. W. (2018) · International Journal of Cancer · doi:10.1002/ijc.31853 · Cited by 58
“Discussion Compelling evidence about changes in histone modification patterns and chromatin structure during cancer development and progression has led to speculation on the function of histone-modifying enzymes in tumorigenesis.(39) Here, we revealed the important pro-proliferative role of SETD1A in ER-positive breas…”
BackgroundFazilaty, H., Gardaneh, M., Bahrami, T., Salmaninejad, A., & Behnam, B. (2013) · Tumor Biology · doi:10.1007/s13277-013-0831-y · Cited by 61
Kogita, A., Togashi, Y., Hayashi, H., Sogabe, S., Terashima, M., Velasco, M. A. D., Sakai, K., Fujita, Y., Tomida, S., Takeyama, Y., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2574 · Cited by 62
“The EMT is a cellular process of morphological change from an epithelial polarized shape to a mesenchymal fibroblastoid shape, in addition to accompanying behavioral changes such as enhanced mobility (18,19).”
BackgroundStress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma
Krook, M. A., Nicholls, L. A., Scannell, C. A., Chugh, R. K., Thomas, D. G., & Lawlor, E. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0668 · Cited by 58
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.